Sanjeev Luther
CIK: 0001933592
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ERNA
Ernexa Therapeutics Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History
About Luther Sanjeev
Luther Sanjeev (SEC CIK 0001933592) files insider reports with the SEC as President and CEO of Ernexa Therapeutics Inc. (ERNA).
Signal8 holds 2 ownership filings by Luther Sanjeev, all Form 4s, filed between Feb 10, 2025 and Sep 1, 2026. Those filings report 2 transactions, the latest on Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Luther Sanjeev's filings is in CAMBRIDGE, MA.
Other insiders filing for Ernexa Therapeutics Inc. (ERNA)
- Spiegel Robert J., Director
- Bristol James Arthur, Director
- Cicala Peter, Director
- Polinsky David, Director
- Wexler William A., Director
- Ratner Elena, Director